Transplanterede patienter, der får immunosuppressiv behandling (f. eks. systemisk tacrolimus) har en id
Transplant patients receiving immunosuppressive regimens (e. g. systemic tacrolimus) are at increased risk for developing lymphoma; therefore patients who receive Protopy and who develop ed